Details of the Drug

General Information of Drug (ID: DMIQB13)

Drug Name
SHAPE
Indication
Disease Entry ICD 11 Status REF
Cutaneous T-cell lymphoma 2B01 Phase 2 [1]
Lymphoma 2A80-2A86 Phase 1 [2]
Cross-matching ID
TTD ID
D0N6AC
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase (HDAC) TTBH0VX NOUNIPROTAC Inhibitor [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Tetralogic pharmaceuticals.
3 Clinical pipeline report, company report or official report of Tetralogic pharmaceuticals.